Found: 11
Select item for more details and to access through your institution.
Exploratory analyses of treatment subgroup interaction by PD-L1 status and according to PD-L1 expression in the JAVELIN Bladder 100 trial.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 6, p. 1532, doi. 10.1007/s12094-023-03358-4
- By:
- Publication type:
- Article
Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach Testori et al. ECT for skin tumors.
- Published in:
- Dermatologic Therapy, 2010, v. 23, n. 6, p. 651, doi. 10.1111/j.1529-8019.2010.01370.x
- By:
- Publication type:
- Article
Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 2, p. 383, doi. 10.1007/s10147-021-02067-8
- By:
- Publication type:
- Article
Avelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib Trial.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 333, doi. 10.1093/oncolo/oyac243
- By:
- Publication type:
- Article
Reliability, validity, and change thresholds of the NCCN/FACT Bladder Symptom Index (NFBlSI‐18) in patients with advanced urothelial cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 1, p. 31, doi. 10.1002/cncr.35025
- By:
- Publication type:
- Article
Meeting Report from the Third Global Workshop on Melanoma.
- Published in:
- 2010
- By:
- Publication type:
- Report
Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Literature as Worldly Action: Representations of Public and Private Dissent in Akwaeke Emezi's The Death of Vivek Oji.
- Published in:
- Matatu: Journal for African Culture & Society, 2023, v. 54, n. 2, p. 301, doi. 10.1163/18757421-05402005
- By:
- Publication type:
- Article
Long-term Safety of Avelumab First-line Maintenance for Advanced Urothelial Carcinoma in the JAVELIN Bladder 100 Trial.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2023, v. 14, n. 11, p. 358
- By:
- Publication type:
- Article
CTLA4 blockade in mesothelioma: finally a competing strategy over cytotoxic/target therapy?
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 1, p. 105, doi. 10.1007/s00262-014-1609-9
- By:
- Publication type:
- Article
Model‐informed drug development supporting the approval of the avelumab flat‐dose regimen in patients with advanced renal cell carcinoma.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 4, p. 458, doi. 10.1002/psp4.12771
- By:
- Publication type:
- Article